The Association of Inflammatory Related Markers with the Prognosis in Elderly Patients with Colorectal Cancer
SW Chiang - Cancer Management and Research, 2024 - Taylor & Francis
Background Colorectal cancer (CRC) is a common malignancy, especially among older
adults. Inflammation has been implicated in cancer progression, making inflammatory …
adults. Inflammation has been implicated in cancer progression, making inflammatory …
[HTML][HTML] Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis
M Kim, IT Son, BY Oh - The Ewha Medical Journal, 2023 - e-emj.org
Colorectal cancer (CRC) is a globally prevalent and challenging malignancy. Accurate
prognosis prediction is essential for optimizing patient care. This comprehensive review …
prognosis prediction is essential for optimizing patient care. This comprehensive review …
Effect of the lymphocyte-to-monocyte ratio on the prognosis of patients with obstructive colorectal cancer with a colonic stent: a retrospective multicenter study in Japan
T Shiraishi, T Tominaga, T Nonaka, Y Takamura… - Surgery Today, 2024 - Springer
Purpose The prognostic value of the lymphocyte-to-monocyte (LMR) ratio has been reported
for various cancers, including colorectal cancer (CRC). The insertion of colonic stents is …
for various cancers, including colorectal cancer (CRC). The insertion of colonic stents is …
The Combination of prognostic nutritional indicator and serum carcinoembryonic antigen is useful in predicting postoperative recurrence in stage II colorectal cancer
C Uejima, H Saito, Y Tada, A Tanio, Y Murakami… - Yonago Acta …, 2021 - jstage.jst.go.jp
Background The efficacy of adjuvant chemotherapy in stage II colorectal cancer (CRC)
patients has not been clearly demonstrated. Therefore, identification of robust prognostic …
patients has not been clearly demonstrated. Therefore, identification of robust prognostic …
[HTML][HTML] Taiwan society of colon and rectum surgeons (TSCRS) consensus for anti-inflammatory nutritional intervention in colorectal cancer
CJ Ma, WH Hu, MC Huang, JM Chiang… - Frontiers in …, 2022 - frontiersin.org
Malnutrition and systemic inflammatory response (SIR) frequently occur in patients with
colorectal cancer (CRC) and are associated with poor prognosis. Anti-inflammatory …
colorectal cancer (CRC) and are associated with poor prognosis. Anti-inflammatory …
Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
W Chen, HJ Yi, XQ Chen, WZ Xie, X Tang, JW Ye… - BMC surgery, 2021 - Springer
Objective This study aimed to investigate the prognostic value of CIP2A (cancerous inhibitor
of protein phosphatase 2A) and the NLR (neutrophil–lymphocyte ratio) in the serum of …
of protein phosphatase 2A) and the NLR (neutrophil–lymphocyte ratio) in the serum of …
[HTML][HTML] 甲状腺影像报告和数据系统的临床应用研究进展
邓凡芝， 周迪军 - Advances in Clinical Medicine, 2023 - hanspub.org
甲状腺结节(TN) 是内分泌最常见的疾病之一, 严重影响广大人民的身心健康. 甲状腺癌(Thyroid
cancer TC) 的早期发现及诊断对甲状腺疾病的治疗及预后具有积极意义. 目前超声(Ultro …
cancer TC) 的早期发现及诊断对甲状腺疾病的治疗及预后具有积极意义. 目前超声(Ultro …
Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a …
A Tanio, H Saito, K Hara, K Sugezawa, C Uejima… - Surgery Today, 2023 - Springer
Purpose We determined the usefulness of the estimation of physiologic ability and surgical
stress (E-PASS), initially reported as a predictive factor for postoperative morbidity and …
stress (E-PASS), initially reported as a predictive factor for postoperative morbidity and …
NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome
M Langheinrich, AR Siebenhüner, J Baecker… - Diagnostics, 2022 - mdpi.com
Background: Colorectal carcinoma (CRC) is a heterogeneous disease, and differences in
outcomes have been reported among patients diagnosed with the same disease stage …
outcomes have been reported among patients diagnosed with the same disease stage …
Prognostic value of lymphocyte-to-C-reactive-protein ratio in cancers
R Liu, W Ma, L Zi, L Zhang, Z Qiu, K Wang, K Zhao… - 2023 - researchsquare.com
Background Systemic inflammation and immune nutritional status affect tumor progression
and patient survival. Lymphocyte-to-C-reactive-protein ratio (LCR) as inflammatory immune …
and patient survival. Lymphocyte-to-C-reactive-protein ratio (LCR) as inflammatory immune …